Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Clin Transplant. 2022 Sep 5;36(11):e14781. doi: 10.1111/ctr.14781

Table 2.

In-hospital outcomes after heart transplantation and short-term mortality

De Novo Heart
Transplant
(N=22,348)		 Durable
LVAD BTT
(N=11014)		 TAH-t BTT
(N=392)		 P value
(TAH-t BTT
vs. LVAD
BTT)		 P-value
(TAH-t BTT
vs. De Novo)
In-hospital Outcomes
Treated acute rejection 10.0 (2225) 10.6 (1172) 7.7 (30) 0.06 0.13
New dialysis requirement 9.4 (2094) 11.4 (1255) 15.3 (60) <0.001 <0.001
Stroke 2.1 (462) 3.7 (406) 8.2 (32) <0.001 <0.001
Permanent pacemaker implant 2.9 (641) 3.0 (333) 2.8 (11) 0.80 0.94
Hospital length of stay (days) 14 (10-22) 16 (11-24) 21 (14-39) <0.001 <0.001
Short-term Outcomes
30-day mortality 3.4 (750) 4.2 (465) 9.2 (36) <0.001 <0.001
90-day mortality 5.4 (1199) 6.4 (708) 12.2 (48) <0.001 <0.001

BTT: Bridge to Transplant; LVAD: Left Ventricular Assist Device; TAH-t: Total Artificial Heart

Values are in % (n) or median (interquartile range)